UCSF researcher Jennifer Mitchell in a lab examining MM120, an LSD-based drug for treating generalized anxiety disorder.

UCSF researchers test LSD-based MM120 for generalized anxiety disorder

Heather Vogel AI द्वारा उत्पन्न छवि तथ्य-जाँच किया गया

UCSF neuroscientist Jennifer Mitchell and collaborators are evaluating MM120, a pharmaceutical form of LSD, as a potential treatment for generalized anxiety disorder. A randomized clinical trial published in JAMA found that a single dose reduced anxiety symptoms versus placebo, with benefits persisting up to 12 weeks in the optimal dose group, according to the study and the drug’s sponsor.

Magnetic gel aids efficient kidney stone removal in pig tests

Researchers at Stanford University have developed a magnetic gel that coats kidney stone fragments, allowing for their removal in bulk using a magnetic wire. Tested successfully in pigs, the technique aims to reduce tissue damage and the need for repeated surgeries compared to standard methods. Experts praise it as a promising alternative to current procedures.

Bone density dips during breastfeeding but recovers quickly

Maria Karlsson

A new study from Lund University shows that bone density drops significantly in breastfeeding women, but recovery happens quickly afterward. The research offers a positive surprise and could influence osteoporosis treatments. Findings come from a ten-year follow-up of 750 women.

Three German hospitals lead in European patent applications

Three German university hospitals rank among Europe's most active research institutions in patent applications. According to a study by the European Patent Office (EPA), these clinics filed numerous patents between 2001 and 2020. Germany holds second place in Europe overall.

Scientists uncover early brain damage before MS symptoms

Heather Vogel

Researchers at UC San Francisco have found that multiple sclerosis damages the brain years before symptoms appear, by analyzing blood proteins. The study identifies key markers like IL-3 and MOG, potentially enabling earlier diagnosis and prevention. This discovery, published in Nature Medicine, could transform how MS is managed.

Researchers explore blockchain for AI ethical alignment

A team of researchers, including those from Penn State University, has investigated how blockchain technology can enforce ethical boundaries on artificial intelligence systems. Their work, published in the Journal of Cybersecurity and Privacy, proposes a framework to ensure AI complies with human values. The study highlights blockchain's potential for transparency and accountability in AI decision-making.

Ketogenic diet protects young rats from prenatal stress effects

Researchers in Italy have found that a ketogenic diet can shield young rats from the long-term mental and behavioral impacts of prenatal stress. The high-fat, low-carbohydrate regimen, administered after weaning, improved sociability and reduced stress-related issues in the offspring of stressed mothers. These findings, presented at the ECNP conference in Amsterdam, suggest potential early dietary interventions, though human trials are needed.

AI forecasts future knee X-rays to track osteoarthritis

Theo Klein

Researchers at the University of Surrey have developed an AI system that predicts a patient's knee X-ray appearance one year ahead, aiding in osteoarthritis management. The tool generates visual forecasts and risk scores, presented at MICCAI 2025. It promises faster, more transparent predictions for better patient care.

Genes influencing cannabis use identified in genome study

Researchers from UC San Diego and 23andMe have discovered genetic links to cannabis use behaviors, connecting them to over 100 health traits. The study, published on October 13, 2025, in Molecular Psychiatry, highlights two key genes and could inform prevention of cannabis use disorder. It analyzed data from nearly 132,000 participants to explore early-stage risks.

Study finds GLP-1 drugs may slow alcohol effects

Researchers at Virginia Tech's Fralin Biomedical Research Institute have published a study suggesting that GLP-1 medications, such as Ozempic and Wegovy, could help reduce alcohol consumption by slowing its absorption into the bloodstream. Participants on these drugs reported feeling less intoxicated after drinking the same amount of alcohol as those not taking them. The findings, from a pilot study involving 20 adults, point to a potential new approach distinct from traditional treatments.

Study shows lipids fuel triple-negative breast cancer growth

Researchers at the Huntsman Cancer Institute have found that triple-negative breast cancer cells depend on lipids for growth, a process accelerated by obesity-related high lipid levels. In mouse models, reducing these lipids slowed tumor progression, suggesting potential new treatments. The findings warn against high-fat diets like keto for obese breast cancer patients.

Different depression types tied to distinct physical health risks

New research shows that atypical depression increases diabetes risk, while melancholic depression heightens chances of heart disease. The findings, from a seven-year study of nearly 6,000 adults, highlight the need for tailored mental and physical health approaches. Presented at the ECNP Congress in Amsterdam, the work underscores biological differences in depression subtypes.

 

 

 

यह वेबसाइट कुकीज़ का उपयोग करती है

हम अपनी साइट को बेहतर बनाने के लिए एनालिटिक्स के लिए कुकीज़ का उपयोग करते हैं। अधिक जानकारी के लिए हमारी गोपनीयता नीति पढ़ें।
अस्वीकार करें